Faeth Therapeutics gets FDA Fast Track for PIKTOR plus paclitaxel in biomarker-selected advanced or recurrent endometrial cancer
https://finviz.com/stock?t=FTH&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.